Cargando…
L-arginine supplementation and thromboxane synthase inhibition increases cerebral blood flow in experimental cerebral malaria
Cerebral malaria pathogenesis involves vascular dysfunction with low nitric oxide (NO) bioavailability, vasoconstriction and impaired vasodilation, leading to ischemia, tissue hypoxia and ultimately death. Cerebral blood flow (CBF) involves NO and other pathways, including arachidonic acid (AA)-deri...
Autores principales: | Moreira, Aline S., Estato, Vanessa, Malvar, David C., Sanches, Guilherme S., Gomes, Fabiana, Tibirica, Eduardo, Daniel-Ribeiro, Cláudio Tadeu, Carvalho, Leonardo J. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6754365/ https://www.ncbi.nlm.nih.gov/pubmed/31541129 http://dx.doi.org/10.1038/s41598-019-49855-x |
Ejemplares similares
-
Whole blood transfusion improves vascular integrity and increases survival in artemether-treated experimental cerebral malaria
por: Gul, Saba, et al.
Publicado: (2021) -
Reversal of cerebrovascular constriction in experimental cerebral malaria by L-arginine
por: Ong, Peng Kai, et al.
Publicado: (2018) -
Cerebral microvascular dysfunction in metabolic syndrome is exacerbated by ischemia–reperfusion injury
por: Obadia, Nathalie, et al.
Publicado: (2017) -
Vascular dysfunction as a target for adjuvant therapy in cerebral
malaria
por: Carvalho, Leonardo José de Moura, et al.
Publicado: (2014) -
Statins Decrease Neuroinflammation and Prevent Cognitive Impairment after Cerebral Malaria
por: Reis, Patricia A., et al.
Publicado: (2012)